Board of Directors
Chair
Steven Holtzman, Chairman
President & CEO, Decibel Therapeutics
Josh Mandel-Brehm
President & CEO, CAMP4 Therapeutics
Jorge Conde
General Partner, Andreessen Horowitz
Michael Higgins
CEO, Kindex Pharmaceuticals
Amir Nashat, ScD
Managing Partner, Polaris Partners
Paula Ragan, PhD
President & CEO, X4 Pharmaceuticals
Richard Young, PhD
Member, Whitehead Institute
Professor of Biology, MIT
Professor of Biology, MIT

Founders
Richard Young, PhD
Member, Whitehead Institute
Professor of Biology, MIT
Professor of Biology, MIT
Leonard Zon, MD
Grousbeck Professor of Pediatric Medicine, Harvard Medical School
Investigator, Howard Hughes Medical Institute
Director, Stem Cell Program, Boston Children’s Hospital
Investigator, Howard Hughes Medical Institute
Director, Stem Cell Program, Boston Children’s Hospital
Business Advisors
Ken DiPietro
Chief Human Resources Officer, Cerevel Therapeutics
Peter Hecht, PhD
CEO, Cyclerion Therapeutics
Doug Williams, PhD
CEO, Codiak Biosciences
Scientific Advisory Board
Chair
Michael Hayden, CM OB CMB ChB PhD FRCP(C) FRSC
University of British Columbia
Jason Buenrostro, PhD
Broad Institute, Harvard University
Felix Frueh, PhD
Opus Three
Wolfram Goessling, MD, PhD
Harvard Medical School/Massachusetts General Hospital/Brigham & Women’s Hospital
Joel Hirschhorn, MD, PhD
Harvard Medical School/Boston Children’s Hospital
Rudolf Jaenisch, MD
Whitehead Institute, Massachusetts Institute of Technology
Benjamin Neale, PhD
Massachusetts General Hospital, Broad Institute
Jay Shendure, MD, PhD
University of Washington